{"id":"W3193211635","doi":"10.1097/hs9.0000000000000617","title":"Adjunctive Volasertib in Patients With Acute Myeloid Leukemia not Eligible for Standard Induction Therapy: A Randomized, Phase 3 Trial","year":2021,"lang":"en","type":"article","venue":"HemaSphere","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Internal medicine; Cytarabine; Hazard ratio; Clinical endpoint; Myeloid leukemia; Randomized controlled trial; Surgery; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006598194,0.0003353906,0.001157341,0.0001312592,0.0001127038,0.00005226259,0.0001151499,0.0002451452,0.0005627338],"category_scores_gemma":[0.0005817205,0.0002414976,0.0002627902,0.0006457682,0.0001533015,0.0002477872,0.00005564446,0.0005549182,0.00002460458],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001390346,"about_ca_system_score_gemma":0.002798938,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001075494,"about_ca_topic_score_gemma":0.00005654989,"domain_scores_codex":[0.9972998,0.0002289218,0.0005563372,0.000643779,0.0006963203,0.0005748681],"domain_scores_gemma":[0.9979571,0.0003333496,0.0001705011,0.0005000932,0.0008518362,0.0001871112],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9694588,0.0006611184,0.0004932379,0.00006921266,0.0007155361,0.0001146471,0.0004121431,0.00001149566,0.002886469,0.00005815547,0.004574042,0.02054521],"study_design_scores_gemma":[0.9175329,0.003827112,0.0003376287,0.0001617577,0.0002410032,0.00002026852,0.0003065181,0.0001916493,0.07067008,0.0001106727,0.006333383,0.0002669955],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9905725,0.0003791067,0.001301661,0.0007154737,0.0002911563,0.005735622,0.0001361291,0.00007493111,0.0007934178],"genre_scores_gemma":[0.9873887,0.0003519533,0.004186712,0.0007193239,0.0004605745,0.001581814,0.0009647942,0.0001391929,0.004206993],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06778361,"threshold_uncertainty_score":0.9847988,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02104062024741899,"score_gpt":0.311902993568538,"score_spread":0.290862373321119,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}